Proceedings of the third international molecular pathological epidemiology (MPE) meeting

被引:0
|
作者
Peter T. Campbell
Timothy R. Rebbeck
Reiko Nishihara
Andrew H. Beck
Colin B. Begg
Alexei A. Bogdanov
Yin Cao
Helen G. Coleman
Gordon J. Freeman
Yujing J. Heng
Curtis Huttenhower
Rafael A. Irizarry
N. Sertac Kip
Franziska Michor
Daniel Nevo
Ulrike Peters
Amanda I. Phipps
Elizabeth M. Poole
Zhi Rong Qian
John Quackenbush
Harlan Robins
Peter K. Rogan
Martha L. Slattery
Stephanie A. Smith-Warner
Mingyang Song
Tyler J. VanderWeele
Daniel Xia
Emily C. Zabor
Xuehong Zhang
Molin Wang
Shuji Ogino
机构
[1] American Cancer Society,Epidemiology Research Program
[2] Harvard T.H. Chan School of Public Health,Department of Epidemiology
[3] Dana-Farber Cancer Institute,Department of Medical Oncology
[4] Harvard Medical School,Department of Nutrition
[5] Harvard T.H. Chan School of Public Health,Cancer Research Institute
[6] Beth Israel Deaconess Cancer Center,Department of Pathology
[7] Harvard Medical School,Department of Epidemiology and Biostatistics
[8] Beth Israel Deaconess Medical Center,Department of Radiology
[9] Memorial Sloan Kettering Cancer Center,Clinical and Translational Epidemiology Unit
[10] University of Massachusetts Medical School,Division of Gastroenterology
[11] Massachusetts General Hospital and Harvard Medical School,Epidemiology and Health Services Research Group, Centre for Public Health
[12] Massachusetts General Hospital and Harvard Medical School,Department of Biostatistics
[13] Queens University Belfast,Microbial Systems and Communities, Genome Sequencing and Analysis Program
[14] Harvard T.H. Chan School of Public Health,Department of Biostatistics and Computational Biology
[15] The Broad Institute,Laboratory Medicine and Pathology
[16] Dana-Farber Cancer Institute,Public Health Sciences Division
[17] Geisinger Health System,Department of Epidemiology, School of Public Health
[18] Fred Hutchinson Cancer Research Center,Channing Division of Network Medicine, Department of Medicine
[19] University of Washington,Department of Biochemistry
[20] Brigham and Women’s Hospital and Harvard Medical School,Department of Pathology
[21] University of Western Ontario,Division of MPE Molecular Pathological Epidemiology, Department of Pathology
[22] University of Utah School of Medicine,Department of Oncologic Pathology
[23] Brigham and Women’s Hospital,undefined
[24] Brigham and Women’s Hospital and Harvard Medical School,undefined
[25] Dana-Farber Cancer Institute,undefined
来源
Cancer Causes & Control | 2017年 / 28卷
关键词
Molecular pathological epidemiology; Meeting report; Proceedings;
D O I
暂无
中图分类号
学科分类号
摘要
Molecular pathological epidemiology (MPE) is a transdisciplinary and relatively new scientific discipline that integrates theory, methods, and resources from epidemiology, pathology, biostatistics, bioinformatics, and computational biology. The underlying objective of MPE research is to better understand the etiology and progression of complex and heterogeneous human diseases with the goal of informing prevention and treatment efforts in population health and clinical medicine. Although MPE research has been commonly applied to investigating breast, lung, and colorectal cancers, its methodology can be used to study most diseases. Recent successes in MPE studies include: (1) the development of new statistical methods to address etiologic heterogeneity; (2) the enhancement of causal inference; (3) the identification of previously unknown exposure-subtype disease associations; and (4) better understanding of the role of lifestyle/behavioral factors on modifying prognosis according to disease subtype. Central challenges to MPE include the relative lack of transdisciplinary experts, educational programs, and forums to discuss issues related to the advancement of the field. To address these challenges, highlight recent successes in the field, and identify new opportunities, a series of MPE meetings have been held at the Dana–Farber Cancer Institute in Boston, MA. Herein, we share the proceedings of the Third International MPE Meeting, held in May 2016 and attended by 150 scientists from 17 countries. Special topics included integration of MPE with immunology and health disparity research. This meeting series will continue to provide an impetus to foster further transdisciplinary integration of divergent scientific fields.
引用
收藏
页码:167 / 176
页数:9
相关论文
共 50 条
  • [1] Proceedings of the third international molecular pathological epidemiology (MPE) meeting
    Campbell, Peter T.
    Rebbeck, Timothy R.
    Nishihara, Reiko
    Beck, Andrew H.
    Begg, Colin B.
    Bogdanov, Alexei A.
    Cao, Yin
    Coleman, Helen G.
    Freeman, Gordon J.
    Heng, Yujing J.
    Huttenhower, Curtis
    Irizarry, Rafael A.
    Kip, N. Sertac
    Michor, Franziska
    Nevo, Daniel
    Peters, Ulrike
    Phipps, Amanda I.
    Poole, Elizabeth M.
    Qian, Zhi Rong
    Quackenbush, John
    Robins, Harlan
    Rogan, Peter K.
    Slattery, Martha L.
    Smith-Warner, Stephanie A.
    Song, Mingyang
    VanderWeele, Tyler J.
    Xia, Daniel
    Zabor, Emily C.
    Zhang, Xuehong
    Wang, Molin
    Ogino, Shuji
    CANCER CAUSES & CONTROL, 2017, 28 (02) : 167 - 176
  • [2] Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting
    Song Yao
    Peter T. Campbell
    Tomotaka Ugai
    Gretchen Gierach
    Mustapha Abubakar
    Viktor Adalsteinsson
    Jonas Almeida
    Paul Brennan
    Stephen Chanock
    Todd Golub
    Samir Hanash
    Curtis Harris
    Cassandra A. Hathaway
    Karl Kelsey
    Maria Teresa Landi
    Faisal Mahmood
    Christina Newton
    John Quackenbush
    Scott Rodig
    Nikolaus Schultz
    Guillermo Tearney
    Shelley S. Tworoger
    Molin Wang
    Xuehong Zhang
    Montserrat Garcia-Closas
    Timothy R. Rebbeck
    Christine B. Ambrosone
    Shuji Ogino
    Cancer Causes & Control, 2022, 33 : 1107 - 1120
  • [3] Proceedings of the second international molecular pathological epidemiology (MPE) meeting
    Shuji Ogino
    Peter T. Campbell
    Reiko Nishihara
    Amanda I. Phipps
    Andrew H. Beck
    Mark E. Sherman
    Andrew T. Chan
    Melissa A. Troester
    Adam J. Bass
    Kathryn C. Fitzgerald
    Rafael A. Irizarry
    Karl T. Kelsey
    Hongmei Nan
    Ulrike Peters
    Elizabeth M. Poole
    Zhi Rong Qian
    Rulla M. Tamimi
    Eric J. Tchetgen Tchetgen
    Shelley S. Tworoger
    Xuehong Zhang
    Edward L. Giovannucci
    Piet A. van den Brandt
    Bernard A. Rosner
    Molin Wang
    Nilanjan Chatterjee
    Colin B. Begg
    Cancer Causes & Control, 2015, 26 : 959 - 972
  • [4] Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting
    Yao, Song
    Campbell, Peter T.
    Ugai, Tomotaka
    Gierach, Gretchen
    Abubakar, Mustapha
    Adalsteinsson, Viktor
    Almeida, Jonas
    Brennan, Paul
    Chanock, Stephen
    Golub, Todd
    Hanash, Samir
    Harris, Curtis
    Hathaway, Cassandra A.
    Kelsey, Karl
    Landi, Maria Teresa
    Mahmood, Faisal
    Newton, Christina
    Quackenbush, John
    Rodig, Scott
    Schultz, Nikolaus
    Tearney, Guillermo
    Tworoger, Shelley S.
    Wang, Molin
    Zhang, Xuehong
    Garcia-Closas, Montserrat
    Rebbeck, Timothy R.
    Ambrosone, Christine B.
    Ogino, Shuji
    CANCER CAUSES & CONTROL, 2022, 33 (08) : 1107 - 1120
  • [5] Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting
    Peter T. Campbell
    Christine B. Ambrosone
    Reiko Nishihara
    Hugo J. W. L. Aerts
    Melissa Bondy
    Nilanjan Chatterjee
    Montserrat Garcia-Closas
    Marios Giannakis
    Jeffrey A. Golden
    Yujing J. Heng
    N. Sertac Kip
    Jill Koshiol
    X. Shirley Liu
    Camila M. Lopes-Ramos
    Lorelei A. Mucci
    Jonathan A. Nowak
    Amanda I. Phipps
    John Quackenbush
    Robert E. Schoen
    Lynette M. Sholl
    Rulla M. Tamimi
    Molin Wang
    Matty P. Weijenberg
    Catherine J. Wu
    Kana Wu
    Song Yao
    Kun-Hsing Yu
    Xuehong Zhang
    Timothy R. Rebbeck
    Shuji Ogino
    Cancer Causes & Control, 2019, 30 : 799 - 811
  • [6] Proceedings of the second international molecular pathological epidemiology (MPE) meeting
    Ogino, Shuji
    Campbell, Peter T.
    Nishihara, Reiko
    Phipps, Amanda I.
    Beck, Andrew H.
    Sherman, Mark E.
    Chan, Andrew T.
    Troester, Melissa A.
    Bass, Adam J.
    Fitzgerald, Kathryn C.
    Irizarry, Rafael A.
    Kelsey, Karl T.
    Nan, Hongmei
    Peters, Ulrike
    Poole, Elizabeth M.
    Qian, Zhi Rong
    Tamimi, Rulla M.
    Tchetgen, Eric J. Tchetgen
    Tworoger, Shelley S.
    Zhang, Xuehong
    Giovannucci, Edward L.
    van den Brandt, Piet A.
    Rosner, Bernard A.
    Wang, Molin
    Chatterjee, Nilanjan
    Begg, Colin B.
    CANCER CAUSES & CONTROL, 2015, 26 (07) : 959 - 972
  • [7] Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting
    Campbell, Peter T.
    Ambrosone, Christine B.
    Nishihara, Reiko
    Aerts, Hugo J. W. L.
    Bondy, Melissa
    Chatterjee, Nilanjan
    Garcia-Closas, Montserrat
    Giannakis, Marios
    Golden, Jeffrey A.
    Heng, Yujing J.
    Kip, N. Sertac
    Koshiol, Jill
    Liu, X. Shirley
    Lopes-Ramos, Camila M.
    Mucci, Lorelei A.
    Nowak, Jonathan A.
    Phipps, Amanda I.
    Quackenbush, John
    Schoen, Robert E.
    Sholl, Lynette M.
    Tamimi, Rulla M.
    Wang, Molin
    Weijenberg, Matty P.
    Wu, Catherine J.
    Wu, Kana
    Yao, Song
    Yu, Kun-Hsing
    Zhang, Xuehong
    Rebbeck, Timothy R.
    Ogino, Shuji
    CANCER CAUSES & CONTROL, 2019, 30 (08) : 799 - 811
  • [8] Evidence from the molecular pathological epidemiology (MPE) - The role of estrogens in colorectal cancer -
    Honma, Naoko
    CANCER SCIENCE, 2018, 109 : 403 - 403
  • [9] proceedings from the Third International Scientific Meeting Matija Vlacic Ilirik
    Majusevic, Mladen
    HISTRIA, 2013, 3 : 368 - 374
  • [10] PROCEEDINGS OF THE THIRD ANNUAL MEETING
    King, John E.
    Small, A. J.
    LAW LIBRARY JOURNAL, 1908, 1 (03): : 41 - 80